Davis, CA, United States of America

Tilahun D Yilma

This inventor holds 2 USPTO granted patents. Top assignee: University of California. Active years: 1998-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tilahun D Yilma. Retrieved from https://idiyas.com/inventor/tilahun-d-yilma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1998-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Tilahun D Yilma

Introduction

Tilahun D Yilma is a prominent inventor based in Davis, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of vaccines and therapeutic agents. With a total of 2 patents, his work focuses on innovative solutions to combat viral infections.

Latest Patents

One of his latest patents is for attenuated lentivirus vectors expressing interferon. This invention discloses recombinant vectors and live attenuated pathogens produced by these vectors, which are useful as vaccines and therapeutic agents. The recombinant viruses are designed to remain at very low virus loads and preferably do not persist in infected hosts. These vectors are particularly useful against retroviruses such as human immunodeficiency virus and acquired immunodeficiency diseases. In these recombinant vectors and pathogens, one or more genes responsible for pathogenesis have been rendered nonfunctional through deletion or mutagenesis. Additionally, the recombinant vectors contain genes encoding cytokines and/or lymphokines.

Another significant patent is for double recombinant vaccinia virus vaccines. This patent describes vaccines comprising a recombinant vaccinia virus that expresses at least two heterologous genes encoding pathogen antigens. A first antigen gene is inserted into the thymidine kinase gene of the vaccinia virus, while a second antigen gene is inserted into the hemagglutinin gene. The hemagglutinin and fusion genes of the rinderpest virus have been specifically inserted into the respective genes of the vaccinia virus. These double recombinant viruses have been found to be highly attenuated while remaining effective in protecting an inoculated host.

Career Highlights

Tilahun D Yilma is affiliated with the University of California, where he continues to advance his research and innovations in the field of biotechnology. His work has garnered attention for its potential impact on public health and disease prevention.

Collaborations

He has collaborated with notable colleagues such as Luis D Giavedoni and Paul A Luciw, contributing to a rich environment of research and innovation.

Conclusion

Tilahun D Yilma's contributions to the field of biotechnology through his patents and research are noteworthy. His innovative approaches to vaccine development hold promise for improving health outcomes in the fight against viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…